Amanote Research
Register
Sign In
Prm102 - Analyzing Real-World Data to Target Hard-To-Identify Patient Populations for Clinical Trials: A Case Study in Metastatic Breast Cancer
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2223
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
S Tzellos
Publisher
Elsevier BV
Related search
Patient Barriers to Participation in Breast Cancer Clinical Trials
Breast Cancer Management
Oncology
Radiology
Nuclear Medicine
Imaging
A Systematic Approach to Preclinical Trials in Metastatic Breast Cancer
Chemotherapy: Open Access
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes Between Clinical Trials and Real World Populations in Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Examining Patient Conceptions: A Case of Metastatic Breast Cancer in an African American Male to Female Transgender Patient
Journal of General Internal Medicine
Internal Medicine
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
Frontiers in Oncology
Cancer Research
Oncology
An Agent-Based Approach to Real-Time Patient Identification for Clinical Trials
Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering
Computer Networks
Communications
Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Breast Cancer Metastatic to the Pituitary Gland: A Case Report
World Journal of Surgical Oncology
Surgery
Oncology
